{"id":3912,"date":"2020-03-04T14:52:04","date_gmt":"2020-03-04T13:52:04","guid":{"rendered":"https:\/\/www.m-q.ch\/?p=3912"},"modified":"2020-03-04T14:52:04","modified_gmt":"2020-03-04T13:52:04","slug":"biosimilars-could-drastically-reduce-healthcare-costs","status":"publish","type":"post","link":"https:\/\/www.m-q.ch\/en\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/","title":{"rendered":"Biosimilars could drastically reduce healthcare costs"},"content":{"rendered":"<figure id=\"attachment_3913\" aria-describedby=\"caption-attachment-3913\" style=\"width: 680px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-3913\" src=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-680x510.jpg\" alt=\"\" width=\"680\" height=\"510\" srcset=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-680x510.jpg 680w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-768x576.jpg 768w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1536x1152.jpg 1536w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-2048x1536.jpg 2048w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-16x12.jpg 16w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-233x175.jpg 233w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-467x350.jpg 467w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1067x800.jpg 1067w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-920x690.jpg 920w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1400x1050.jpg 1400w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1867x1400.jpg 1867w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-300x225.jpg 300w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1024x768.jpg 1024w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-624x468.jpg 624w\" sizes=\"auto, (max-width: 680px) 100vw, 680px\" \/><figcaption id=\"caption-attachment-3913\" class=\"wp-caption-text\">A study by the ZHAW calculates potential cost reductions in healthcare for the six most important active ingredients alone. (Image: Unsplash)<\/figcaption><\/figure>\n<p class=\"bodytext\">Switzerland could drastically reduce pharmaceutical costs by increasing the prescription of biosimilars. This is the conclusion of a study by the Winterthur Institute for Health Economics (<a href=\"https:\/\/www.zhaw.ch\/de\/sml\/institute-zentren\/wig\/\" target=\"_blank\" rel=\"noopener\">TIG<\/a>) of the ZHAW School of Management and Law (<a href=\"https:\/\/www.zhaw.ch\/de\/sml\/?pi=1825&amp;cHash=455ffccb9ab0ab263837ca9820641c01\" target=\"_blank\" rel=\"noopener\">SML<\/a>). It is affiliated with the Zurich University of Applied Sciences (<a href=\"https:\/\/www.zhaw.ch\/de\/hochschule\/\" target=\"_blank\" rel=\"noopener\">ZHAW<\/a>) affiliated.<\/p>\n<p class=\"bodytext\">Unlike in other European countries, biosimilars are only used with restraint in Switzerland. These copycat medicines of original preparations that are no longer patent-protected are in no way inferior to the originals in terms of efficacy and safety. At the same time, they are up to 25 percent cheaper. However, fewer biosimilars have been approved in Switzerland than in the European Union. In addition, doctors have less experience with biosimilars than with the original products.<\/p>\n<p class=\"bodytext\">\"We were able to show in our analysis that the increased use of biosimilars in Switzerland could significantly reduce the drug costs of mandatory health insurance,\" the head of the Winterthur-based institute, Simon Wieser, is quoted as saying in a\u00a0<a href=\"https:\/\/www.zhaw.ch\/de\/ueber-uns\/aktuell\/news\/detailansicht-news\/event-news\/biosimilars-koennten-schweizer-gesundheitskosten-um-millionen-senken\/\" target=\"_blank\" rel=\"noopener\">Media release<\/a>\u00a0quoted. The authors estimate the potential savings for six of the most important active ingredients at up to 100 million Swiss francs over three years. To achieve this, new patients would have to be prescribed more biosimilars. If people who had previously taken original preparations were also switched to biosimilars, the savings would be even higher.<\/p>\n<p class=\"bodytext\"><em>The expert report \"Biosimilars in Switzerland - Medicine to counter rising healthcare costs?\" was prepared by the Winterthur Institute for Health Economics on behalf of\u00a0<a href=\"https:\/\/www.pfizer.ch\/\" target=\"_blank\" rel=\"noopener\">Pfizer<\/a>\u00a0compiled<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Die Schweiz k\u00f6nnte durch die vermehrte Verschreibung von Biosimilars die Arzneimittelkosten drastisch senken. Zu diesem Ergebnis kommt eine Studie des Winterthurer Instituts f\u00fcr Gesundheits\u00f6konomie (WIG) der ZHAW School of Management and Law\u00a0(SML). Sie ist der Z\u00fcrcher Hochschule f\u00fcr Angewandte Wissenschaften (ZHAW) angegliedert. Anders als in anderen europ\u00e4ischen L\u00e4ndern werden in der Schweiz Biosimilars nur zur\u00fcckhaltend [&hellip;]<\/p>\n","protected":false},"author":35,"featured_media":3913,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3303],"tags":[4247,4248,3490,4223],"class_list":["post-3912","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-qualitaetsmanagement","tag-arzneimittel","tag-kosten","tag-schweiz","tag-studien"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken - MQ Management und Qualit\u00e4t<\/title>\n<meta name=\"description\" content=\"Die Schweiz sch\u00f6pft das Sparpotenzial bei bestimmten nachgeahmten Medikamenten, sogenannten Biosimilars, bei weitem nicht aus, belegt eine ZHAW Studie.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.m-q.ch\/en\/biosimilars-could-drastically-reduce-healthcare-costs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken - MQ Management und Qualit\u00e4t\" \/>\n<meta property=\"og:description\" content=\"Die Schweiz sch\u00f6pft das Sparpotenzial bei bestimmten nachgeahmten Medikamenten, sogenannten Biosimilars, bei weitem nicht aus, belegt eine ZHAW Studie.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.m-q.ch\/en\/biosimilars-could-drastically-reduce-healthcare-costs\/\" \/>\n<meta property=\"og:site_name\" content=\"MQ Management und Qualit\u00e4t\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ManagementUndQualitaet\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-04T13:52:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Roger Str\u00e4ssle\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Roger Str\u00e4ssle\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\"},\"author\":{\"name\":\"Roger Str\u00e4ssle\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/47d540e081acd98ccbeb69b55df653d7\"},\"headline\":\"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken\",\"datePublished\":\"2020-03-04T13:52:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\"},\"wordCount\":268,\"publisher\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\",\"keywords\":[\"Arzneimittel\",\"Kosten\",\"Schweiz\",\"Studien\"],\"articleSection\":[\"Qualit\u00e4tsmanagement\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\",\"url\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\",\"name\":\"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken - MQ Management und Qualit\u00e4t\",\"isPartOf\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\",\"datePublished\":\"2020-03-04T13:52:04+00:00\",\"description\":\"Die Schweiz sch\u00f6pft das Sparpotenzial bei bestimmten nachgeahmten Medikamenten, sogenannten Biosimilars, bei weitem nicht aus, belegt eine ZHAW Studie.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage\",\"url\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\",\"contentUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\",\"width\":2560,\"height\":1920,\"caption\":\"Eine Studie der ZHAW errechnet allein bei den sechs wichtigsten Wirkstoffen m\u00f6gliche Kostensenkungen im Gesundheitswesen. (Bild: Unsplash)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Qualit\u00e4tsmanagement\",\"item\":\"https:\/\/www.m-q.ch\/kategorie\/qualitaetsmanagement\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#website\",\"url\":\"https:\/\/www.m-q.ch\/fr\/\",\"name\":\"MQ Management und Qualit\u00e4t\",\"description\":\"Plattform f\u00fcr integrierte Managementsysteme.\",\"publisher\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.m-q.ch\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#organization\",\"name\":\"Galledia Fachmedien AG\",\"url\":\"https:\/\/www.m-q.ch\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png\",\"contentUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png\",\"width\":512,\"height\":512,\"caption\":\"Galledia Fachmedien AG\"},\"image\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ManagementUndQualitaet\",\"https:\/\/www.linkedin.com\/showcase\/17982321\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/47d540e081acd98ccbeb69b55df653d7\",\"name\":\"Roger Str\u00e4ssle\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e4dde3046d8a184d2e2d27651a418883?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e4dde3046d8a184d2e2d27651a418883?s=96&d=mm&r=g\",\"caption\":\"Roger Str\u00e4ssle\"},\"url\":\"https:\/\/www.m-q.ch\/en\/author\/roger-straessle\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biosimilars could drastically reduce healthcare costs - MQ Management und Qualit\u00e4t","description":"Switzerland is far from exploiting the savings potential of certain imitation medicines, so-called biosimilars, according to a ZHAW study.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.m-q.ch\/en\/biosimilars-could-drastically-reduce-healthcare-costs\/","og_locale":"en_US","og_type":"article","og_title":"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken - MQ Management und Qualit\u00e4t","og_description":"Die Schweiz sch\u00f6pft das Sparpotenzial bei bestimmten nachgeahmten Medikamenten, sogenannten Biosimilars, bei weitem nicht aus, belegt eine ZHAW Studie.","og_url":"https:\/\/www.m-q.ch\/en\/biosimilars-could-drastically-reduce-healthcare-costs\/","og_site_name":"MQ Management und Qualit\u00e4t","article_publisher":"https:\/\/www.facebook.com\/ManagementUndQualitaet","article_published_time":"2020-03-04T13:52:04+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","type":"image\/jpeg"}],"author":"Roger Str\u00e4ssle","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Roger Str\u00e4ssle","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#article","isPartOf":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/"},"author":{"name":"Roger Str\u00e4ssle","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/47d540e081acd98ccbeb69b55df653d7"},"headline":"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken","datePublished":"2020-03-04T13:52:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/"},"wordCount":268,"publisher":{"@id":"https:\/\/www.m-q.ch\/fr\/#organization"},"image":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","keywords":["Arzneimittel","Kosten","Schweiz","Studien"],"articleSection":["Qualit\u00e4tsmanagement"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/","url":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/","name":"Biosimilars could drastically reduce healthcare costs - MQ Management und Qualit\u00e4t","isPartOf":{"@id":"https:\/\/www.m-q.ch\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage"},"image":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","datePublished":"2020-03-04T13:52:04+00:00","description":"Switzerland is far from exploiting the savings potential of certain imitation medicines, so-called biosimilars, according to a ZHAW study.","breadcrumb":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage","url":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","contentUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","width":2560,"height":1920,"caption":"Eine Studie der ZHAW errechnet allein bei den sechs wichtigsten Wirkstoffen m\u00f6gliche Kostensenkungen im Gesundheitswesen. (Bild: Unsplash)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Qualit\u00e4tsmanagement","item":"https:\/\/www.m-q.ch\/kategorie\/qualitaetsmanagement\/"},{"@type":"ListItem","position":2,"name":"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken"}]},{"@type":"WebSite","@id":"https:\/\/www.m-q.ch\/fr\/#website","url":"https:\/\/www.m-q.ch\/fr\/","name":"MQ Management and Quality","description":"Platform for integrated management systems.","publisher":{"@id":"https:\/\/www.m-q.ch\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.m-q.ch\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.m-q.ch\/fr\/#organization","name":"Galledia Trade Media AG","url":"https:\/\/www.m-q.ch\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png","contentUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png","width":512,"height":512,"caption":"Galledia Fachmedien AG"},"image":{"@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ManagementUndQualitaet","https:\/\/www.linkedin.com\/showcase\/17982321\/admin\/"]},{"@type":"Person","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/47d540e081acd98ccbeb69b55df653d7","name":"Roger Str\u00e4ssle","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e4dde3046d8a184d2e2d27651a418883?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e4dde3046d8a184d2e2d27651a418883?s=96&d=mm&r=g","caption":"Roger Str\u00e4ssle"},"url":"https:\/\/www.m-q.ch\/en\/author\/roger-straessle\/"}]}},"_links":{"self":[{"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/posts\/3912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/comments?post=3912"}],"version-history":[{"count":1,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/posts\/3912\/revisions"}],"predecessor-version":[{"id":3914,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/posts\/3912\/revisions\/3914"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/media\/3913"}],"wp:attachment":[{"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/media?parent=3912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/categories?post=3912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/tags?post=3912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}